We are live on ! Find out more
AAMU

Amundi Asset Management US Portfolio holdings

AUM $131B
1-Year Est. Return 73.57%
This Fund
S&P 500
This Quarter Est. Return
+3.16%
1 Year Est. Return
+73.57%
3 Year Est. Return
+113.87%
5 Year Est. Return
+203.49%
10 Year Est. Return
–
AUM
$69.4B
AUM Growth
+$6.98B
Cap. Flow
+$4.09B
Cap. Flow %
5.89%
Top 10 Hldgs %
17.22%
Holding
1,674
New
131
Increased
736
Reduced
517
Closed
111

Top Buys

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$544M
2
PEP icon
PepsiCo
PEP
+$334M
3
EMR icon
Emerson Electric
EMR
+$333M
4
COST icon
Costco
COST
+$245M
5
T icon
AT&T
T
+$243M

Top Sells

Rank Stock Value
1
TWX
Time Warner Inc
TWX
+$653M
2
C icon
Citigroup
C
+$242M
3
EOG icon
EOG Resources
EOG
+$230M
4
AVGO icon
Broadcom
AVGO
+$223M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$167M

Sector Composition

Rank Sector Weight
1 Technology 18.32%
2 Financials 14.81%
3 Healthcare 12.34%
4 Consumer Discretionary 11.9%
5 Industrials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PDSB icon
1401
PDS Biotechnology
PDSB
$43.4M
$81K ﹤0.01%
+3,920
New +$81.8K
HBIO icon
1402
Harvard Bioscience
HBIO
$29.2M
$80K ﹤0.01%
+1,490
New +$76.3K
CENT icon
1403
Central Garden & Pet Co
CENT
$2.8B
$78K ﹤0.01%
2,250
– –
KPTI icon
1404
Karyopharm Therapeutics
KPTI
$48M
$78K ﹤0.01%
307
– –
CMRX
1405
DELISTED
Chimerix, Inc.
CMRX
$78K ﹤0.01%
16,300
– –
MTGE
1406
DELISTED
MTGE Investment Corp. Common Stock
MTGE
$78K ﹤0.01%
4,000
– –
ENIC icon
1407
Enel Chile
ENIC
$6.28B
$77K ﹤0.01%
15,840
– –
MACK
1408
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$77K ﹤0.01%
19,828
+2,797
+16% +$18.6K
RDI icon
1409
Reading International Class A
RDI
$34.3M
$73K ﹤0.01%
+4,600
New +$73.2K
ADAP
1410
DELISTED
Adaptimmune Therapeutics
ADAP
$70K ﹤0.01%
5,909
– –
XBIT icon
1411
XBiotech
XBIT
$69.2M
$70K ﹤0.01%
15,694
– –
ERIC icon
1412
Ericsson
ERIC
$33.3B
$67K ﹤0.01%
8,700
– –
STDY
1413
DELISTED
SteadyMed Ltd
STDY
$67K ﹤0.01%
14,967
– –
ADVM
1414
DELISTED
Adverum Biotechnologies
ADVM
$66K ﹤0.01%
+1,240
New +$74.6K
NVCR icon
1415
NovoCure
NVCR
$1.91B
$65K ﹤0.01%
2,066
– –
TNK icon
1416
Teekay Tankers
TNK
$2.68B
$64K ﹤0.01%
6,888
– –
LTRPA
1417
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$64K ﹤0.01%
4,000
-11,000
-73% -$142K
NTGN
1418
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$63K ﹤0.01%
+5,000
New +$68.5K
FOMX
1419
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$63K ﹤0.01%
12,600
– –
ATEX icon
1420
Anterix
ATEX
$1.94B
$62K ﹤0.01%
2,500
– –
SCTL
1421
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$62K ﹤0.01%
+13,715
New +$109K
SBBP
1422
DELISTED
Strongbridge Biopharma plc.
SBBP
$62K ﹤0.01%
10,400
– –
SVA
1423
DELISTED
Sinovac Biotech, Ltd
SVA
$62K ﹤0.01%
8,300
– –
AFMD
1424
DELISTED
Affimed
AFMD
$61K ﹤0.01%
3,710
– –
ADAM
1425
Adamas Trust
ADAM
$883M
$61K ﹤0.01%
2,550
– –
55 56
57
58 59

Similar funds

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
SHP
Spruce House Partnership New York $3.49B AUM
SBSB
Sullivan, Bruyette, Speros & Blaney Mclean, Virginia $2.27B AUM 50.71% 1-Year Est. Return
PAG
Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return
BUB
BBVA USA Bancshares Houston, Texas $2.1B AUM 62.57% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
PPCM
Pillar Pacific Capital Management Pacifica, California $1.29B AUM 80.18% 1-Year Est. Return
AAM
Anglepoint Asset Management George Town, Cayman Islands $1.28B AUM 131.9% 1-Year Est. Return

Amundi Asset Management US's Q2 2018 Portfolio in Review

As of Q2 2018, Amundi Asset Management US held 1,674 positions worth $69.4B, up 11% from $62.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Amundi Asset Management US deployed $4.09B of net new capital in Q2 2018, opening 131 new positions and adding to 736 existing holdings. Its largest new stake was Cactus: 648,373 shares worth $21.9M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Citigroup, an estimated $242M trimmed.

  • Amundi Asset Management US's largest Q2 2018 buy was Cactus: 648,373 shares worth $21.9M.
  • Amundi Asset Management US added most to Booking.com in Q2 2018, an estimated $544M increase.
  • Amundi Asset Management US's biggest Q2 2018 reduction was Citigroup, cutting an estimated $242M.
  • Amundi Asset Management US fully exited Time Warner Inc in Q2 2018, selling an estimated $653M.
  • Amundi Asset Management US's ten largest holdings make up 17% of its $69.4B portfolio in Q2 2018.
  • Amundi Asset Management US opened 131 new positions and closed 111 in Q2 2018.
  • Amundi Asset Management US's portfolio value rose 11% quarter-over-quarter to $69.4B.

Based on Amundi Asset Management US's 13F filing for Q2 2018, filed 13 Aug 2018.